Company / Current Assets
Janux Therapeutics, Inc. Current Assets History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$975.9M
FY2025
5-year range
$332.4M / $1.0B
FY2021-FY2025
Trend
-5.6%
vs FY2024
Sector context
#53 of 215
Health Care
What the data says
Janux Therapeutics, Inc.'s current assets of $976M is higher than 75% of companies in the Health Care sector (FY2025). Current Assets has fluctuated over the past 6 years, ranging from $16M in FY2020 to $1.0B in FY2024.
Based on SEC 10-K filings.
$976M in FY2025 with a 5-year CAGR of +127.4%. Top quartile in the Health Care sector.
Improved from $349M to $976M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +43.2%
- 5-Year CAGR
- +127.4%
- 10-Year CAGR
- -
Sector benchmark
-61.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +127.4%, indicating consistent growth.
- In FY2025, current assets decreased 5.6% year-over-year.
- Ranks #53 out of 215 companies in the Health Care sector.
- Peak current assets was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 9.17 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $975.9M | -5.6% |
| FY2024 | $1.0B | +196.0% |
| FY2023 | $349.2M | +5.1% |
| FY2022 | $332.4M | -11.8% |
| FY2021 | $377.0M | +2247.3% |
| FY2020 | $16.1M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026